Ogren S O, Berge O G
Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):135-40. doi: 10.1007/BF00501202.
Administration of the serotonin (5-HT) releasing compound p-chloroamphetamine (PCA; 2.5 mg/kg) induced potent analgesia in rats tested with the hot plate method. The analgesia was prevented by pretreatment with either of the 5-HT uptake inhibitors alaproclate (20 mg/kg) or fluoxetine (10 mg/kg). Taking into account that the noradrenergic uptake inhibitor desipramine in previous experiments failed to interfere with the effect of PCA, these results demonstrate that PCA selectively acts on 5-HT terminals. The analgesia was attenuated by administration of the 5-HT antagonists methiothepin (0.125-0.5 mg/kg) and danitracen (0.25-2.5 mg/kg) but not by a series of other 5-HT receptor antagonists or antagonists acting on noradrenergic, dopaminergic, GABAergic, histaminergic or muscarinic receptors. It is concluded that the analgesic effect of PCA is mediated via stimulation of a type of 5-HT receptors possibly belonging to the 5-HT-1 class. Further studies are, however, needed in order to firmly establish the relationship to any particular sub-type of 5-HT receptor as characterized in in vitro binding studies.
给予5-羟色胺(5-HT)释放化合物对氯苯丙胺(PCA;2.5毫克/千克),在用热板法测试的大鼠中诱导出强效镇痛作用。用5-HT摄取抑制剂阿普氯胺(20毫克/千克)或氟西汀(10毫克/千克)预处理可预防这种镇痛作用。鉴于在先前实验中去甲肾上腺素能摄取抑制剂地昔帕明未能干扰PCA的作用,这些结果表明PCA选择性作用于5-HT终末。给予5-HT拮抗剂甲硫噻平(0.125 - 0.5毫克/千克)和达尼曲辛(0.25 - 2.5毫克/千克)可减弱镇痛作用,但一系列其他5-HT受体拮抗剂或作用于去甲肾上腺素能、多巴胺能、GABA能、组胺能或毒蕈碱能受体的拮抗剂则无此作用。得出的结论是,PCA的镇痛作用是通过刺激一种可能属于5-HT-1类的5-HT受体介导的。然而,为了牢固确立与体外结合研究中所表征的任何特定5-HT受体亚型的关系,还需要进一步研究。